Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
n-3 PUFAs for Cocaine Addiction Relapse
NCT00312455Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Jul 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of eicosapentaenoic acid, docosapentaenoic acid in cocaine dependence, alcohol dependence, sponsored by National Institute on Drug Abuse. Started Jul 2004; status: completed.
02
Drugs
eicosapentaenoic aciddocosapentaenoic acid
03
Conditions
cocaine dependencealcohol dependence
Beyond the preview
Go deeper on NCT00312455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312455.